BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33569382)

  • 1. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
    Zhou H; Ni WJ; Meng XM; Tang LQ
    Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M; Natarajan R
    Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
    Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
    Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions Among Non-Coding RNAs in Diabetic Nephropathy.
    Loganathan TS; Sulaiman SA; Abdul Murad NA; Shah SA; Abdul Gafor AH; Jamal R; Abdullah N
    Front Pharmacol; 2020; 11():191. PubMed ID: 32194418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.
    Tu C; Wei L; Wang L; Tang Y
    Diabetes Metab Syndr Obes; 2022; 15():907-920. PubMed ID: 35359345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.
    Lanzaro F; Barlabà A; De Nigris A; Di Domenico F; Verde V; Miraglia Del Giudice E; Di Sessa A
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cooperative Gene Regulation Among Transcription Factors, LncRNAs, and MicroRNAs in Diabetic Nephropathy Progression.
    Chen L; Wu B; Wang S; Xiong Y; Zhou B; Cheng X; Zhou T; Luo R; Lam TW; Yan B; Chen J
    Front Genet; 2020; 11():1008. PubMed ID: 33088282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
    Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
    Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Targets in Diabetic Nephropathy.
    Donate-Correa J; Luis-Rodríguez D; Martín-Núñez E; Tagua VG; Hernández-Carballo C; Ferri C; Rodríguez-Rodríguez AE; Mora-Fernández C; Navarro-González JF
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy.
    Fan B; Chopp M; Zhang ZG; Liu XS
    Front Neurol; 2020; 11():558758. PubMed ID: 33192992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Epigenetics of Diabetic Nephropathy.
    Liu R; Lee K; He JC
    Kidney Dis (Basel); 2015 May; 1(1):42-51. PubMed ID: 27536664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy.
    Tang J; Yao D; Yan H; Chen X; Wang L; Zhan H
    Int J Endocrinol; 2019; 2019():8719060. PubMed ID: 31885563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.
    Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D
    BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNAs in diabetic nephropathy.
    Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
    J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Li H; Zhu X; Zhang J; Shi J
    Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.